We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$283M 4.89%
+1,309,500
New +$283M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$206M 3.56%
5,299,900
+254,840
+5% +$9.68M
AAPL icon
3
Apple
AAPL
$4.89T
$148M 2.55%
5,233,272
-38,588
-0.7% -$1.02M
META icon
4
Meta Platforms (Facebook)
META
$1.51T
$133M 2.29%
1,034,179
+64,423
+7% +$8M
CB icon
5
Chubb
CB
$140B
$111M 1.91%
880,431
-238,285
-21% -$30.2M
MSFT icon
6
Microsoft
MSFT
$2.84T
$104M 1.79%
1,798,193
+187,401
+12% +$10.6M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.91T
$103M 1.78%
2,557,760
-960
-0% -$37.5K
PFE icon
8
Pfizer
PFE
$140B
$93.2M 1.61%
2,899,065
-1,979,467
-41% -$66.2M
ACGL icon
9
Arch Capital
ACGL
$36.1B
$93M 1.6%
3,518,151
+16,626
+0.5% +$423K
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$90.3M 1.56%
625,117
-274
-0% -$40.1K
MKL icon
11
Markel Group
MKL
$25B
$84.2M 1.45%
90,651
-893
-1% -$833K
AMZN icon
12
Amazon
AMZN
$2.5T
$81.6M 1.41%
1,950,000
+382,660
+24% +$14.6M
INTC icon
13
Intel
INTC
$464B
$80.4M 1.39%
2,130,351
+26,918
+1% +$953K
V icon
14
Visa
V
$677B
$80.1M 1.38%
969,037
-34,997
-3% -$2.8M
MRK icon
15
Merck
MRK
$324B
$79.4M 1.37%
1,334,104
+904,424
+210% +$52.9M
JPM icon
16
JPMorgan Chase
JPM
$939B
$79.2M 1.37%
1,189,707
-21,344
-2% -$1.39M
SU icon
17
Suncor Energy
SU
$77.7B
$74.6M 1.29%
2,296,958
-170,129
-7% -$4.65M
VR
18
DELISTED
Validus Hold Ltd
VR
$74.1M 1.28%
1,486,557
+24,660
+2% +$1.23M
C icon
19
Citigroup
C
$222B
$73.4M 1.27%
1,554,105
+37,294
+2% +$1.7M
LVNTA
20
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$70.8M 1.22%
1,776,738
+187,807
+12% +$7.32M
JNJ icon
21
Johnson & Johnson
JNJ
$634B
$68.5M 1.18%
579,721
-236,398
-29% -$28.7M
MDT icon
22
Medtronic
MDT
$107B
$67.7M 1.17%
783,715
-228,823
-23% -$19.9M
PEP icon
23
PepsiCo
PEP
$186B
$67.3M 1.16%
618,277
+19,369
+3% +$2.09M
ELV icon
24
Elevance Health
ELV
$81.9B
$63.7M 1.1%
508,539
+23,291
+5% +$3.01M
BABA icon
25
Alibaba
BABA
$269B
$62.2M 1.07%
587,824
-72,226
-11% -$6.69M
1
2 3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.